NCCN News

Restricted access
  • 1.

    Schadendorf D, Wolchok JD, Hodi FS, et al. . Efficacy and safety outcomes in patients with advanced melanoma who discontinued treatment with nivolumab and ipilimumab because of adverse events: a pooled analysis of randomized phase II and III trials. J Clin Oncol 2017;35:38073814.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 1.

    Esparza SD, Sakamoto KM. Topics in pediatric leukemia-acute lymphoblastic leukemia. MedGenMed 2005;7:23.

  • 2.

    Ma H, Sun H, Sun X. Survival improvement by decade of patients aged 0-14 years with acute lymphoblastic leukemia: a SEER analysis. Sci Rep 2014;4:4227.


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 103 58 8
PDF Downloads 49 38 3
EPUB Downloads 0 0 0